Currently out of the existing stock ratings of Irma Sgarz, 5 are a HOLD (27.78%), 13 are a BUY (72.22%).

Irma Sgarz

Work Performance Price Targets & Ratings Chart

Analyst Irma Sgarz, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 57.58% that have a potential upside of 24.59% achieved within 269 days.

Irma Sgarz’s has documented 33 price targets and ratings displayed on 4 stocks. The coverage is on the Consumer Cyclical sector.

Most recent stock forecast was given on MELI, MercadoLibre at 14-May-2025.

Wall Street Analyst Irma Sgarz

Analyst best performing recommendations are on MELI (MERCADOLIBRE).
The best stock recommendation documented was for MELI (MERCADOLIBRE) at 2/8/2018. The price target of $378 was fulfilled within 7 days with a profit of $32.69 (9.47%) receiving and performance score of 13.52.

Average potential price target upside

MELI MercadoLibre AFYA Afya Ltd NTCO Natura Holding SA VTRU Vitru Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 15-Jul-2026

$2000

$122.05 (6.50%)

$2700

19 days ago
(15-Jul-2026)

8/12 (66.67%)

$156.81 (8.51%)

310

Buy Since 05-Aug-2021

$2150

$272.05 (14.49%)

$2150

2 months 1 days ago
(02-Jun-2026)

24/31 (77.42%)

$477.17 (28.52%)

125

Buy Since 05-Aug-2021

$2300

$422.05 (22.47%)

$2500

2 months 23 days ago
(11-May-2026)

16/23 (69.57%)

$742.7 (47.69%)

287

Buy Since 07-Jan-2020

$2450

$572.05 (30.46%)

$2600

2 months 23 days ago
(11-May-2026)

8/11 (72.73%)

$892.7 (57.32%)

457

Buy Since 15-Apr-2025

$2380

$502.05 (26.73%)

$2780

2 months 26 days ago
(08-May-2026)

1/7 (14.29%)

$747.48 (45.79%)

27

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Irma Sgarz?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?